JENNIFER O'NEILL: Open Payments
NPI 1063096501 · SUMMIT, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$724 in 38 payments from 11 companies in 2025. Trend: 2023 $235 · 2024 $921 · 2025 $724
Food & beverage: $724
| Company | Payments | Amount |
|---|---|---|
| QOL Medical, LLC | 7 | $160 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 9 | $137 |
| Janssen Biotech, Inc. | 6 | $115 |
| PFIZER INC. | 5 | $93 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $81 |
| Aimmune Therapeutics, Inc. | 2 | $31 |
| Exact Sciences Corporation | 1 | $29 |
| Madrigal Pharmaceuticals | 1 | $23 |
| Lilly USA, LLC | 1 | $20 |
| Ipsen Biopharmaceuticals, Inc | 1 | $19 |
Products named: Sucraid, XIFAXAN, TREMFYA, ENTYVIO, VELSIPITY, XELJANZ, ZENPEP, Cologuard Collection Kit.
Industry payments across NJ — which companies pay providers there.
